- Home
- ILAG vs VCEL Comparison
ILAG vs VCEL Comparison
Compare ILAG & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- VCEL
- Stock Information
- Founded
- ILAG 1981
- VCEL 1989
- Country
- ILAG Hong Kong
- VCEL United States
- Employees
- ILAG N/A
- VCEL 357
- Industry
- ILAG Office Equipment/Supplies/Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ILAG Consumer Discretionary
- VCEL Health Care
- Exchange
- ILAG Nasdaq
- VCEL Nasdaq
- Market Cap
- ILAG N/A
- VCEL 2.1B
- IPO Year
- ILAG 2022
- VCEL 1997
- Fundamental
- Price
- ILAG $0.40
- VCEL $41.09
- Analyst Decision
- ILAG
- VCEL Strong Buy
- Analyst Count
- ILAG 0
- VCEL 8
- Target Price
- ILAG N/A
- VCEL $61.75
- AVG Volume (30 Days)
- ILAG 56.8K
- VCEL 550.6K
- Earning Date
- ILAG 05-06-2025
- VCEL 05-08-2025
- Dividend Yield
- ILAG N/A
- VCEL N/A
- EPS Growth
- ILAG N/A
- VCEL N/A
- EPS
- ILAG N/A
- VCEL 0.20
- Revenue
- ILAG $8,980,747.00
- VCEL $237,224,000.00
- Revenue This Year
- ILAG N/A
- VCEL $23.23
- Revenue Next Year
- ILAG N/A
- VCEL $24.41
- P/E Ratio
- ILAG N/A
- VCEL $202.45
- Revenue Growth
- ILAG 33.03
- VCEL 20.10
- 52 Week Low
- ILAG $0.35
- VCEL $37.76
- 52 Week High
- ILAG $1.35
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ILAG 47.44
- VCEL 42.58
- Support Level
- ILAG $0.35
- VCEL $39.32
- Resistance Level
- ILAG $0.40
- VCEL $42.02
- Average True Range (ATR)
- ILAG 0.03
- VCEL 2.57
- MACD
- ILAG 0.01
- VCEL 0.20
- Stochastic Oscillator
- ILAG 70.55
- VCEL 48.68
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.